Anixa Biosciences (ANIX) Non-Current Assets (2010 - 2026)
Anixa Biosciences (ANIX) recorded Non-Current Assets of $163,000 in fiscal Q3 2026 (quarter ended Jul 31, 2026), down 19.3% from $202,000 a year earlier and down 5.8% from the prior quarter.
Powered by 
Analysis
Anixa Biosciences (ANIX) Non-Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025 (ended Oct 31, 2025), Anixa Biosciences reported Non-Current Assets of $193,000, down 15.7% from FY2024.
- Annual Non-Current Assets has a five-year compound annual growth rate of 18.0% (FY2020 to FY2025).
- Across earlier fiscal years, Non-Current Assets came in at $229,000 in FY2024 (+38.0%), $166,000 in FY2023 (-21.7%), $212,000 in FY2022 (-16.5%) and $254,000 in FY2021 (+201.2%).
- The fiscal Q3 2026 figure is the lowest quarterly Non-Current Assets since fiscal Q2 2024.
- On a year-over-year basis, Non-Current Assets rose in three of the last seven quarters, with growth averaging 9.0%.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 815.0% in fiscal Q2 2022, against a decline of 25.4% in fiscal Q2 2024 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Anixa Biosciences | 96.15 Mn | 81.01 Mn | - | 163,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 163,000.00 |
| Apr 30, 2026 | 173,000.00 |
| Oct 31, 2025 | 193,000.00 |
| Jul 31, 2025 | 202,000.00 |
| Apr 30, 2025 | 211,000.00 |
| Jan 31, 2025 | 220,000.00 |
| Oct 31, 2024 | 229,000.00 |
| Jul 31, 2024 | 238,000.00 |
| Apr 30, 2024 | 141,000.00 |
| Jan 31, 2024 | 153,000.00 |
| Oct 31, 2023 | 166,000.00 |
| Jul 31, 2023 | 178,000.00 |
| Apr 30, 2023 | 189,000.00 |
| Jan 31, 2023 | 201,000.00 |
| Oct 31, 2022 | 212,000.00 |
| Jul 31, 2022 | 223,000.00 |
| Apr 30, 2022 | 234,000.00 |
| Jan 31, 2022 | 244,000.00 |
| Oct 31, 2021 | 254,000.00 |
| Jul 31, 2021 | 10,411.00 |
API Access
Anixa Biosciences Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=ANIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "ANIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=ANIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();